Myelodysplasia paranoia: Iron as the new radon
- 30 September 2009
- journal article
- editorial
- Published by Elsevier in Leukemia Research
- Vol. 33 (9), 1158-1163
- https://doi.org/10.1016/j.leukres.2008.10.017
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overloadInternational Journal of Hematology, 2008
- Elevated serum ferritin in patients with a myelodysplastic syndrome: How much of a problem?American Journal of Hematology, 2008
- Transfusion‐associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignanciesTransfusion Medicine, 2008
- Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromesLeukemia Research, 2007
- Elevated Ferritin Is Associated with Poorer Survival Following Nonablative Allogeneic Transplantation.Blood, 2007
- Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic SyndromesJournal of Clinical Oncology, 2007
- Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantationBlood, 2007
- Iron Chelation Therapy for Myelodysplastic Syndrome: If and WhenMayo Clinic Proceedings, 2006
- Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision MakingJournal of Clinical Oncology, 2005
- Myelodysplastic Syndromes — Coping with Ineffective HematopoiesisNew England Journal of Medicine, 2005